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ABSTRACT 
 
Nocturia is one of the common disorders that are associated with certain complications such as 
fracture and declined quality of life in addition to disrupting sleep. We, therefore, sought to review 
the evidence on the effects and action mechanisms of medicinal plants on nocturia.  
Methods: The search terms of interest were used to retrieve relevant articles published between 
2000 and 2018 and indexed in the databases Institute for Scientific Information, PubMed, and 
Scopus using EndNote software.  
Peganum harmala and Cannabis sativa are two of the plants that have been reported to be 
effective on nocturia. In addition, certain plant-based derivatives such as SagaPro and certain 
combinations such as Gosha-jinki-gan, paladin kashaya, and PRO 160/120 from Viola odorata L. 
(Violaceae), C.A.Mey. From Echium amoenum Fisch. (Boraginaceae), and Physalis alkekengi L. 
(Solanaceae) help improve nocturia through different mechanisms.  
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As with other types of treatments, plants and plant-based compounds cannot be used as 
monotherapy in treating nocturia, and therefore should be used as a complementary therapy 
alongside available treatments for this disorder to induce the best therapeutic effects. 
 
 
Keywords: Medicinal plant; nocturia; lower urinary tract; symptoms. 
 
1. INTRODUCTION 
 
Nocturia is one of the most common disorders of 
lower urinary tract symptoms (LUTS) [1] and 
refers to waking up to urinate more than once 
each night [2]. This disorder is associated with 
certain complications such as benign prostatic 
obstruction and overactive bladder as well as 
serious adverse effects on quality of life in the 
affected people [1,3]. The people with nocturia 
are faced with disruption in night’s sleep [4,5] 
that affects different aspects of health adversely. 
Inadequate night’s sleep leads ultimately to 
increased mortality rate [6]. In addition, these 
people are likely to fall down and to develop 
fracture especially femur fracture [7]. Because 
this disease is multifactorial, single drug 
therapies are not sufficiently efficacious [8]. 
Therefore, nocturia is treated by multiple 
treatments including improvement of lifestyle, 
chemical drugs, alpha-blockers, antimuscarinic 
agents, antidiuretic therapy, and surgery [9].The 
treatments for night time urination mainly include 
urotherapy and different drugs such as 
desmopressin, imipramine, and anticholinergic 
drugs as well as behavioral therapies [10,11]. 
However, these treatments should be promoted 
[10]. Medicinal plants can represent effective 
treatments for different diseases including urinary 
tract disorders. The popularity of these plants 
has increased considerably because of 
comparatively lower cost and fewer side effects 
[12-19]. Regarding the complications of nocturia, 
the present review was conducted to investigate 
the effects and action mechanisms of the 
medicinal plants on this night time disorder. 
 
2. MATERIALS AND METHODS 
 
To conduct this systematic review, the search 
terms Nocturia or Nocturnal voids in combination 
with Herb, Medicinal plant, and Phyto were used 
to retrieve relevant articles published between 
2000 and 2018 and indexed in the databases 
Institute for Scientific Information, PubMed, and 
Scopus using EndNote software. Then, the 
plants and products that were reported to be 
effective on and therefore control nocturia were 
identified and, according to the research team’s 
comments, included in the study. Studies that 
directly examined their effect on nocturia and 
showed positive effects were investigated. The 
studies that Fig. 1 illustrates how the articles 
were examined for inclusion in the analysis and 
explains the inclusion criteria. 
 
3. RESULTS 
 
The medicinal plants such as Serenoa repens, 
Pygeum africanum, Urtica dioica, and Cucurbita 
pepo were reported to be the most important 
medicinal plants effective on nocturia and certain 
compounds such as isoflavones, lycopene, 
selenium, and beta-sitosterol are being 
addressed for treating the symptoms associated 
with benign prostate hyperplasia (BPH) such as 
nocturia [20]. Because BPH causes certain 
symptoms such as nocturia, decreased voided 
urine volume, the sensory urgency to urinate, the 
frequency of urination during the day or night, 
inability to start and stop a urine stream [21], 
most studies have reported nocturia to be one of 
the symptoms to measure the severity of BPH. 
Table 1 summarizes the evidence on the plants 
and the phytochemical compounds that are 
effective on nocturia. 
 
Several compounds and formulations exist that 
are used in traditional medicine to treat nocturia. 
Gosha-jinki-gan (GJG) is a combination made up 
of 10 plants that are used in Japanese traditional 
medicine. This formula includes Rehmanniae 
Radix, Achyranthis Radix, Coprni Fructus, 
Dioscoreae Rhizoma, Plantaginis Semen, 
Alismatis Rhizoma, Hoclen, Moutan Cortex, 
Cinnamomi Cortex and Aconiti Tuber. 
 
The six-week treatment with this combination 
(2.5 g GJG mixture x 3/day) can help improve 
disorders of urination such as nocturia [25]. 
Another study showed that this combination, 
without interaction with alpha1-blockers or 
antimuscarinic agents, contributed to treating 
nocturia [26]. However, Yoshimura et al. reported 
that furosemide was more efficient in decreasing 
nocturia than GJG [27]. Pataladi kashaya that 
compose of Patola – Trichosanthes, dioica, 
Triphala, Amla – Emblica officinalis, Haritaki – 
Terminalia chebula, Vibhitaki – Terminalia 
bellirica, Arishta – Nimba – Neem – Azadirachta 
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indica, Guduchi – Tinospora cordifolia, Dhavani – 
Solanum indicium, Vrisha – Vasa – Adhatoda 
vasica, Karanja – Pongamia pinnata, is a drug 
used in Ayurvedic medicine that is useful to 
improve BPH symptoms including nocturia in 
addition to decreasing such symptoms [28].   
 
Oelke et al. studied a plant-based combination 
called PRO 160/120 (extracts from saw palmetto 
fruits and stinging nettle roots), and reported that 
nocturia score, according to the International 
Prostate Symptom Score (IPSS), decreased [29]. 
A study on the effects of hydroalcoholic extracts 
of Viola odorata L. (Violaceae), C.A.Mey. 
(Boraginaceae), Echium amoenum Fisch., and 
Physalis alkekengi L. (Solanaceae) showed that 
this combination caused IPSS including nocturia 
to decline [30]. It has been even reported that 
herbal capsules work better in treating nocturia 
than allopathic medicine [31].  
 
 
 
Fig. 1. The flowchart of examining articles according to exclusion and inclusion criteria 
 
A total 103 Studies were found 
from electronic database 
59 Studies were considered for 
inclusion  
12 Studies excluded for full text in non-
English languages 
 
71 Candidate studies retrieved for 
initial evaluation  
32 Studies excluded due to out of the date, 
scope and duplication 
12 Studies with complete data 
were included in final analysis 
47 Studies were exclude for not fulfilling 
inclusion criteria and unavailable full text 
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Table 1. Medicinal plants and their phytochemical compounds effective on nocturia 
 
References Main effects and mechanisms Part of plant/ 
Isolated from 
Plants/ 
phytocompounds name  
[22] Effect on cannabinoid receptors 
in the bladder and nervous 
system 
Extracts containing 
delta-9-
tetrahydrocannabinol 
and cannabidiol 
Cannabis sativa 
[23] Improvement in  BPH 
symptoms including nocturia 
Extract Peganum harmala 
[24] Reduce the score of nocturnal 
bladder capacity index (NBC 
index) 
Angelica rchangelica SagaPro 
 
A number of non-clinical and in vitro studies have 
reported that some plants are effective on 
nocturia. For example, Pygeum africanum [32-
34], rye pollen [35], and Serenoa repens [36-41], 
and also plant compound such as Cernilton 
[32,42,43] and beta-sitosterols (B-sitosterol) [44] 
have been found to decrease one of the 
complications associated with nocturia.  
 
Antiandrogenic action, the antiproliferative effect 
exerted through the inhibition of growth factors, 
anti-inflammatory/anti-oedematous effect and 
prolactin signal modulation are certain 
mechanisms that have been proposed for 
treating BPH and associated complications [40]. 
However, the action mechanisms of the 
medicinal plants in treating nocturia remain 
ambiguous. Certain plants and their derivatives 
have been reported to control nocturia through 
decreasing irritable bladder via affecting spinal 
kappa-opioid receptors [45] distributing water 
among different organs of the body and 
decreasing urination [45] and decreasing 
oxidative stress. Oxidative stress through 
damage to the urothelium imposes an adverse 
effect on sensitizing bladder afferent [46]. 
Besides that, oxidative stress leads to the 
overactive bladder through mediating capsaicin-
sensitive C-fibers [47].  
 
Plants and their compounds exert good 
antioxidant effects due to phenolic compounds 
and vitamins E and C; therefore, they can control 
oxidative stress and help treat nocturia. Although 
plants and their derivatives can effectively 
decrease LUTS, some studies have reported that 
monotherapy is not effective in decreasing the 
symptoms especially nocturia [48-50]. In 
addition, it is necessary to use a combination of 
the plants or their compounds to treat the 
disease so that more optimal results can be 
achieved [51].  
Accordingly, as with routine treatments for these 
two disorders, phytotherapies should be used as 
complementary therapies to achieve better 
outcomes. In addition, some plants can exert 
diuretic effects. Prescribing these plants for the 
people with this disorder should be taken into 
account to avoid an increase in the associated 
complications [52]. 
 
Regarding nocturnal enuresis in children, there is 
convincing evidence on the effects of herbal 
drugs in treating this disorder [53]. Therefore, 
finely-designed clinical trials on their active 
compounds and with large sample size should be 
conducted to supplement available evidence on 
this subject.  
 
Nocturia is multifactorial disease and more 
common among women [54,55] but In the elderly 
nocturia is more frequent among men [54] and it 
should be noted that in the treatment with 
medicinal plants, the causes of nocturia and 
gender differences should be considered. For 
example, nocturnal polyuria and decreased 
nocturnal bladder capacity are the major causes 
of nocturia in women [56]. Testosterone 
deficiency and prostatic hyperplasia (BPH) are 
the leading cause of nocturia in men [57,58]. 
Hence, in the use of medicinal plants, must 
considering the gender factor and underlying 
disorders that cause nocturia,  
 
4. CONCLUSION 
 
Plants and plant-based compounds cannot be 
used alone to treat nocturia and should be used 
as a complementary therapy with routine 
treatments to produce best therapeutic effects. 
Many studies have been conducted on nocturia 
as a symptom of BPH but very few studies have 
investigated it independently. Further clinical 
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trials should be therefore conducted to obtain 
more reliable evidence. 
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